Chemours
434 hedge funds and large institutions have $1.72B invested in Chemours in 2025 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 156 increasing their positions, 89 reducing their positions, and 59 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 89
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
39% more call options, than puts
Call options by funds: $25.1M | Put options by funds: $18.1M
34% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 59
7.58% more ownership
Funds ownership: 92.46% → 100.04% (+7.6%)
4% more funds holding
Funds holding: 419 → 434 (+15)
8% less capital invested
Capital invested by funds: $1.87B → $1.72B (-$154M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$48.6M |
| 2 |
Millennium Management
New York
|
+$38.2M |
| 3 |
SCM
Scopia Capital Management
New York
|
+$15.8M |
| 4 |
AWAM
Appian Way Asset Management
New York
|
+$15.1M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$121M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$38.9M |
| 3 |
JP Morgan Chase
New York
|
-$24.2M |
| 4 |
KCM
Khrom Capital Management
Miami Beach,
Florida
|
-$19.3M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$13.5M |
CC Hedge Fund Activity: Q2 2025 in Review
434 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2025, worth a combined $1.72B — down 8.3% from $1.87B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new CC positions and 59 closed out — a net gain of 20 holders — while 156 added to existing stakes and 89 trimmed.
The largest buyer was BlackRock, adding an estimated $48.6M. The largest seller was Fidelity Investments, cutting an estimated $121M.
- 434 institutional investors held Chemours (CC) as of Q2 2025, up from 419 in Q1 2025.
- Funds reported $1.72B of Chemours stock for Q2 2025, down 8.3% quarter-over-quarter.
- 79 funds opened new Chemours positions in Q2 2025 and 59 closed out, a net change of +20 holders.
- The largest Chemours buyer in Q2 2025 was BlackRock, an estimated $48.6M added.
- The largest Chemours seller in Q2 2025 was Fidelity Investments, an estimated $121M sold.
Based on aggregated 13F filings for Q2 2025.